25254000: Procainamide hydrochloride (substance)

SNOMED CT Concept\Substance\...

\Drug or medicament (substance)\agent cardiovasculaire\Antiarrhythmic agent (substance)\Class I antiarrhythmic agent\Class Ia antiarrhythmic agent (substance)\Procainamide hydrochloride

\Substance categorised by structure\Chemical\Chemical categorized by structure\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative\Substance with benzamide structure (substance)\Procainamide hydrochloride

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative\Substance with benzamide structure (substance)\Procainamide hydrochloride

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Procainamide hydrochloride	Is a	Product containing procainamide (medicinal product)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Procainamide hydrochloride	Is a	Procainamide	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Procainamide hydrochloride	Is a	Drug allergen by structure	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Procainamide hydrochloride	Is a	Class Ia antiarrhythmic agent (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Procainamide hydrochloride	Is a	Benzamide (substance)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Procainamide hydrochloride	Is modification of (attribute)	Procainamide	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Procainamide hydrochloride	Is a	Substance with benzamide structure (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
chlorhydrate de procaïnamide 100 mg/mL, ampoule de 10 mL de solution pour injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)
Procainamide hydrochloride 250 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)
Procainamide hydrochloride 500 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)
Procainamide hydrochloride 500 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)
Procainamide hydrochloride 250 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)
Procainamide hydrochloride 1000mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)
Procainamide hydrochloride 500mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)
Procainamide hydrochloride 250mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)
Procainamide hydrochloride 750mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)
Procainamide hydrochloride 500mg/mL injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)
Procainamide hydrochloride 250 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Procainamide hydrochloride 250 mg oral tablet	Has basis of strength substance (attribute)	True	Procainamide hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Procainamide hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Procainamide hydrochloride 500 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Procainamide hydrochloride 500 mg oral tablet	Has basis of strength substance (attribute)	True	Procainamide hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Procainamide hydrochloride 500 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Procainamide hydrochloride 500 mg oral capsule	Has basis of strength substance (attribute)	True	Procainamide hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Procainamide hydrochloride 250 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Procainamide hydrochloride 250 mg oral capsule	Has basis of strength substance (attribute)	True	Procainamide hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral capsule (clinical drug)	Has basis of strength substance (attribute)	True	Procainamide hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Procainamide hydrochloride 750mg prolonged-release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)
Procainamide hydrochloride 250mg prolonged-release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)
Procainamide hydrochloride 500 mg prolonged-release oral tablet	Has basis of strength substance (attribute)	True	Procainamide hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Procainamide hydrochloride 500 mg prolonged-release oral tablet	Has precise active ingredient	True	Procainamide hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely procainamide hydrochloride 1 gram/1 each prolonged-release oral tablet (clinical drug)	Has precise active ingredient	True	Procainamide hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely procainamide hydrochloride 1 gram/1 each prolonged-release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Procainamide hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Procainamide hydrochloride 250 mg oral tablet	Has precise active ingredient	True	Procainamide hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Procainamide hydrochloride 500 mg oral tablet	Has precise active ingredient	True	Procainamide hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Procainamide hydrochloride 500 mg oral capsule	Has precise active ingredient	True	Procainamide hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Procainamide hydrochloride 250 mg oral capsule	Has precise active ingredient	True	Procainamide hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral capsule (clinical drug)	Has precise active ingredient	True	Procainamide hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Procainamide hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
42334019	Procainamide hydrochloride	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
42335018	Procaine amide hydrochloride	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
755550017	Procainamide hydrochloride (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
42334019	Procainamide hydrochloride	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
42334019	Procainamide hydrochloride	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
42335018	Procaine amide hydrochloride	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
42335018	Procaine amide hydrochloride	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
755550017	Procainamide hydrochloride (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
755550017	Procainamide hydrochloride (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
835671000172111	chlorhydrate de procaïnamide	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
835671000172111	chlorhydrate de procaïnamide	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module